SCHEMBL4757294

SCHEMBL4757294

CC(C)(C)OC(=O)NCc1cc(Cl)ccc1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
IDO1 P14902 2/20 0.48
DDR1 Q08345 3/20 0.45
KDM4A O75164 1/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 1/20 0.41
GLA P06280 1/20 0.41
MAPT P10636 1/20 0.41
XBP1 P17861 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ANO1 Q5XXA6 1/20 0.41
DRD2 P14416 1/20 0.41
HDAC10 Q969S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29793580 1.00 GAA (0.49) GAAIDO1DDR1KDM4AALDH1A1
SCHEMBL16971616 0.89 IDO1 (0.51) GAAIDO1DDR1KDM4AALDH1A1
SCHEMBL18719605 0.86 KDM4A (0.45) GAAKDM4AALDH1A1SMN1; SMN2HDAC10
SCHEMBL27988801 0.86 IDO1 (0.53) GAAIDO1DDR1KDM4AALDH1A1
SCHEMBL6921464 0.86 IDO1 (0.50) GAAIDO1DDR1KDM4AALDH1A1
SCHEMBL3734185 0.84 ANO1 (0.51) GAAIDO1KDM4AALDH1A1HPGD
SCHEMBL31705342 0.84 KDM4A (0.44) GAAKDM4AALDH1A1HDAC10HDAC6
SCHEMBL23105713 0.83 KDM4A (0.43) GAAKDM4AHDAC10HDAC6EPAS1
SCHEMBL21987969 0.83 IDO1 (0.48) GAAIDO1DDR1KDM4AALDH1A1
SCHEMBL2866065 0.83 KDM4A (0.43) GAAIDO1KDM4ASMN1; SMN2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067353-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 WO disclosed
EP-1981854-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS Brystol-Myers Squibb Company (US) 2008-10-22 EP disclosed
WO-2007070826-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed